Table 1 Extract from the patient’s laboratory results between February 2021 and June 2021
From: Management of a patient with common variable immunodeficiency and hepatopathy
unit | material | reference | results | ||||||
|---|---|---|---|---|---|---|---|---|---|
value | |||||||||
date | 02/03/2021 | 02/11/2021 | 02/24/2021 | 03/11/2021 | 04/15/2021 | 06/04/2021 | |||
total bilirubin | mg/dl | serum | ≤ 1,2 | 2 | 2,3 | 0,5 | |||
aspartate aminotransferase (GOT/AST) | U/l | serum | ≤ 49 | 341 | 266 | 242 | 209 | 62 | 84 |
alanine aminotransferase (GPT/ALT) | U/l | serum | ≤ 49 | 895 | 810 | 528 | 406 | 84 | 142 |
gamma-glutamyltransferase (gamma − GT) | U/l | serum | ≤ 59 | 665 | 648 | 593 | 480 | 145 | 97 |
alkaline phosphatase | U/l | serum | 40–130 | 408 | 392 | 207 | 250 | ||
immunoglobulin G (IgG) | g/l | serum | 7,00–16,00 | 2,21 | 1,93 | 4,28 | 5,29 | 9,5 | 8,8 |
immunoglobulin A (IgA) | g/l | serum | 0,70–4,00 | < 0,05 | < 0,10 | < 0,05 | < 0,05 | < 0,05 | |
immunoglobulin M (IgM) | g/l | serum | 0,40–2,30 | < 0,05 | < 0,10 | < 0,05 | < 0,05 | < 0,05 | |
albumin | g/dl | serum | 3,5–5,2 | 4,1 | 4 | ||||